Who owns ALZAMEND NEURO INC COM NEW 2025?

Tip: Access positions for across all investors

Analyze quarterly positions in Alzamend Neuro Inc Com New 2025 with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Alzamend Neuro Inc Com New 2025 stock

Who bought or sold ALZAMEND NEURO INC COM NEW 2025 this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Geode Capital Management 46k $48k 66% Mar 2026
 View chart
Vanguard Group 22k $39k 0% Dec 2025
 View chart
Vanguard Fiduciary Trust 21k $22k 100% Mar 2026
 View chart
Morgan Stanley 18k $19k 0% Mar 2026
 View chart
Virtu Financial 13k $23k 100% Dec 2025
 View chart
XTX Topco 13k $23k 100% Dec 2025
 View chart
Hartland & Co 10k $11k 0% Mar 2026
 View chart
Citigroup 5.2k $5.5k 100% Mar 2026
 View chart
UBS Group 4.5k $4.8k -82% Mar 2026
 View chart
Vanguard Capital Management 4.4k $4.7k 100% Mar 2026
 View chart
Tower Research Capital 2.1k $3.8k 30% Dec 2025
 View chart
BlackRock 437.00 $463.001500 0% Mar 2026
 View chart
SBI Securities 22.00 $23.001000 0% Mar 2026
 View chart
Caitong International Asset Management 4.00 $4.000000 100% Mar 2026
 View chart
Harbor Investment Advisory 1.00 $1.000000 0% Mar 2026
 View chart

Who sold out of Alzamend Neuro Inc Com New 2025?

Fund or Company Name Date Sold Shares Held Valued At
DRW Holdings Dec 2025 116k $212k